Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael L Johnson

Showing results (31-40 of 190) with videos related to

Pageof 19
Sort By:
Drugs & Aging|September 29, 2012
Comparative risk of cerebrovascular adverse events in community-dwelling older adults using risperidone, olanzapine and quetiapine: a multiple propensity score-adjusted retrospective cohort studySatabdi Chatterjee, Hua Chen, Michael L Johnson, et al.
Drugs & Aging|October 2, 2010
Risk of falls and fractures in older adults using antipsychotic agents: a propensity-matched retrospective cohort studySandhya Mehta, Hua Chen, Michael L Johnson, et al.
The American Journal of Geriatric Pharmacotherapy|November 26, 2008
Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patientsRajender R Aparasu, Elda Jano, Michael L Johnson, et al.
The American Journal of Geriatric Pharmacotherapy|February 7, 2012
Risk of falls and fractures in older adults using atypical antipsychotic agents: a propensity score-adjusted, retrospective cohort studySatabdi Chatterjee, Hua Chen, Michael L Johnson, et al.
The American Journal of Managed Care|December 25, 2004
Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular diseaseMichael L Johnson, Kenneth Pietz, David S Battleman, et al.
Antimicrobial Agents and Chemotherapy|August 20, 2014
Validation of a model to predict the risk of nephrotoxicity in patients receiving colistinKady Phe, Michael L Johnson, Hannah R Palmer, et al.
Plos One|May 29, 2014
Potential factors affecting survival differ by run-timing and location: linear mixed-effects models of Pacific salmonids (Oncorhynchus spp.) in the Klamath River, CaliforniaRebecca M Quiñones, Marcel Holyoak, Michael L Johnson, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 2, 2003
Characterization of leptin pulse dynamics and relationship to fat mass, growth hormone, cortisol, and insulinPolyxeni Koutkia, Bridget Canavan, Michael L Johnson, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
Comparative effectiveness of different angiotensin-converting enzyme inhibitors on the risk of hospitalization in patients with heart failureAbhishek S Chitnis, Rajender R Aparasu, Hua Chen, et al.
Journal of the American Pharmacists Association : Japha|October 27, 2015
Potentially inappropriate anticholinergic medication use in older adults with dementiaNandita Kachru, Ryan M Carnahan, Michael L Johnson, et al.
Pageof 19

Showing results (31-40 of 190) with videos related to

Sort By:
Pageof 19
Drugs & Aging|September 29, 2012
Comparative risk of cerebrovascular adverse events in community-dwelling older adults using risperidone, olanzapine and quetiapine: a multiple propensity score-adjusted retrospective cohort studySatabdi Chatterjee, Hua Chen, Michael L Johnson, et al.
Drugs & Aging|October 2, 2010
Risk of falls and fractures in older adults using antipsychotic agents: a propensity-matched retrospective cohort studySandhya Mehta, Hua Chen, Michael L Johnson, et al.
The American Journal of Geriatric Pharmacotherapy|November 26, 2008
Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patientsRajender R Aparasu, Elda Jano, Michael L Johnson, et al.
The American Journal of Geriatric Pharmacotherapy|February 7, 2012
Risk of falls and fractures in older adults using atypical antipsychotic agents: a propensity score-adjusted, retrospective cohort studySatabdi Chatterjee, Hua Chen, Michael L Johnson, et al.
The American Journal of Managed Care|December 25, 2004
Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular diseaseMichael L Johnson, Kenneth Pietz, David S Battleman, et al.
Antimicrobial Agents and Chemotherapy|August 20, 2014
Validation of a model to predict the risk of nephrotoxicity in patients receiving colistinKady Phe, Michael L Johnson, Hannah R Palmer, et al.
Plos One|May 29, 2014
Potential factors affecting survival differ by run-timing and location: linear mixed-effects models of Pacific salmonids (Oncorhynchus spp.) in the Klamath River, CaliforniaRebecca M Quiñones, Marcel Holyoak, Michael L Johnson, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 2, 2003
Characterization of leptin pulse dynamics and relationship to fat mass, growth hormone, cortisol, and insulinPolyxeni Koutkia, Bridget Canavan, Michael L Johnson, et al.
Journal of Comparative Effectiveness Research|November 19, 2013
Comparative effectiveness of different angiotensin-converting enzyme inhibitors on the risk of hospitalization in patients with heart failureAbhishek S Chitnis, Rajender R Aparasu, Hua Chen, et al.
Journal of the American Pharmacists Association : Japha|October 27, 2015
Potentially inappropriate anticholinergic medication use in older adults with dementiaNandita Kachru, Ryan M Carnahan, Michael L Johnson, et al.
Pageof 19